/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Valued at around $39 billion by market cap, Edwards Lifesciences Corporation (EW) operates in the medical devices sector. The California-based company specializes in innovative solutions for advanced cardiovascular diseases, including tissue heart valves and hemodynamic monitoring systems for critically ill patients.
Shares of the medical device maker have significantly underperformed the broader market over the past 52 weeks. EW has declined 17.1% during this period, contrasting with the S&P 500 Index's ($SPX) robust rally of 19.6%. In 2024, EW shares dipped 15.2%, lagging behind SPX's 12% gain on a YTD basis.